TerrAscend director granted 150,000 new options
TerrAscend Corp. director Craig A. Collard reported compensation-related option changes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TerrAscend Corp. director Craig A. Collard reported compensation-related option changes. He received an award of 150,000 employee share options, each allowing purchase of one common share at an exercise price of $0.26 per share, expiring on April 24, 2029.
In a separate transaction on the same date, he disposed of 150,000 existing employee share options back to the issuer at an exercise price of $6.44 per share, also expiring on April 24, 2029. These are non-market transactions reflecting option grant and return to the company, not open-market buying or selling of common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Employee Share Option (Right to Buy) | 150,000 | $0.00 | $0.00 |
| Grant/Award | Employee Share Option (Right to Buy) | 150,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. See remarks.
Key Figures
Key Terms
Grant, award, or other acquisition financial
Disposition to issuer financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TerrAscend (TSNDF) director Craig Collard report on this Form 4?
How many options were granted to Craig Collard in the TerrAscend (TSNDF) filing?
What is the exercise price and expiration of the new TerrAscend options?
What options did Craig Collard dispose of in this TerrAscend (TSNDF) Form 4?
Is Craig Collard’s TerrAscend Form 4 part of his compensation?
AI-generated analysis. How Rhea-AI works. Not financial advice.